Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2017

01-01-2017 | Gastrointestinal Oncology

Identifying Candidates for Early Discharge After Gastrectomy: “It’s Tough to Make Predictions, Especially About the Future”

Author: John T. Mullen

Published in: Annals of Surgical Oncology | Issue 1/2017

Login to get access

Excerpt

The duration of postoperative hospitalization has traditionally been much longer in Korea and Japan than in the West due to both cultural differences and health care systems in the East that allow patients to stay in the hospital longer with less financial impact. Indeed, the reported median hospital stay after gastrectomy for gastric cancer in most series from Korea and Japan is about 9–13 days, and this despite the fact that the majority of gastrectomies currently performed in the East are laparoscopic distal gastrectomies for early gastric cancer. …
Literature
1.
Jeong O, Park YK, Jung MR, Ryu SY. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine. 2015;94:e3140.CrossRef
2.
Merkow RP, Ju MH, Chung JW, et al. Underlying reasons associated with hospital readmission following surgery in the United States. JAMA. 2015;313:483–95.CrossRefPubMed
3.
Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. J Am Coll Surg. 2014;218:1215–22.CrossRefPubMed
4.
Dutta S, Fullarton GM, Forshaw MJ, Horgan PG, McMillan DC. Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical-site infectious complications. World J Surg. 2011;35:1017–25.CrossRefPubMed
5.
Platt JJ, Ramanathan ML, Crosbie RA, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol. 2012;19:4168–77.CrossRefPubMed
6.
Garcia-Granero A, Frasson M, Flor-Lorente B, et al. Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Dis Colon Rectum. 2013;56:475–83.CrossRefPubMed
7.
Adamina M, Warschkow R, Naf F, Hummel B, Rduch T, Lange J, Steffen T. Monitoring C-reactive protein after laparoscopic colorectal surgery excludes infectious complications and allows for safe and early discharge. Surg Endosc. 2014;28:2939–48.CrossRefPubMed
8.
Shishido Y, Fujitani K, Yamamoto K, Hirao M, Tsujinaka T, Sekimoto M. C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer. 2016;19:293–301.CrossRefPubMed
9.
Zhang K, Xi H, Wu X, et al. Ability of serum C-reactive protein concentrations to predict complications after laparoscopy-assisted gastrectomy: a prospective cohort study. Medicine. 2016;95:e3798.CrossRefPubMedPubMedCentral
10.
Metadata
Title
Identifying Candidates for Early Discharge After Gastrectomy: “It’s Tough to Make Predictions, Especially About the Future”
Author
John T. Mullen
Publication date
01-01-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5452-4

Other articles of this Issue 1/2017

Annals of Surgical Oncology 1/2017 Go to the issue

Palliative Care

A Singular Hope: How the Discussion Around Cancer Surgery Sometimes Fails

Hepatobiliary Tumors

KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases

Hepatobiliary Tumors

Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm)

Breast Oncology

Breast Cancer in Male Adolescents and Young Adults

Breast Oncology

Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement

Melanomas

Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients